索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]赵丽敏,辛权达,赵兴胜.三酰甘油葡萄糖指数与心血管疾病相关性研究现状[J].国际心血管病杂志,2023,06:358-361.
点击复制

三酰甘油葡萄糖指数与心血管疾病相关性研究现状(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年06期
页码:
358-361
栏目:
综述
出版日期:
2023-11-20

文章信息/Info

Title:
-
作者:
赵丽敏; 辛权达; 赵兴胜
010110 呼和浩特, 内蒙古医科大学内蒙古临床医学院（赵丽敏, 辛权达）；010017 呼和浩特, 内蒙古自治区人民医院心血管内科（赵兴胜）
Author(s):
-
关键词:
三酰甘油- 葡萄糖指数; 胰岛素抵抗; 心血管疾病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.06.006
文献标识码:
-
摘要:
三酰甘油葡萄糖（TyG）指数可用于胰岛素抵抗的评估。研究证实，胰岛素抵抗与心血管疾病的发生、发展和预后有关。该文介绍TyG 指数与多种心血管疾病发生、发展、预后的相关性及可能的机制。
Abstract:
-

参考文献/References

[1] Virani SS, Alonso A, Benjamin EJ, et al. Heart disease andstroke statistics—2020 update: a report from the AmericanHeart Association[J]. Circulation, 2020, 141(9):e139-e596.
[2] Ormazabal V, Nair S, Elfeky O, et al. Association betweeninsulin resistance and the development of cardiovasculardisease[J]. Cardiovasc Diabetol, 2018, 17(1):122.
[3] Placzkowska S, Pawlik-Sobecka L, Kokot I, et al. Indirectinsulin resistance detection: current clinical trends andlaboratory limitations[J]. Biomed Pap Med Fac Univ PalackyOlomouc Czech Repub, 2019, 163(3):187-199.
[4] Vasques ACJ, Novaes FS, de Oliveira MDS, et al. TyG indexperforms better than HOMA in a Brazilian population: ahyperglycemic clamp validated study[J]. Diabetes Res ClinPract, 2011, 93(3):e98-e100.
[5] Thai PV, Tien HA, Van Minh H, et al. Triglyceride glucoseindex for the detection of asymptomatic coronary arterystenosis in patients with type 2 diabetes[J]. CardiovascDiabetol, 2020, 19(1):137.
[6] Su JY, Li Z, Huang MN, et al. Triglyceride glucose indexfor the detection of the severity of coronary artery disease indifferent glucose metabolic states in patients with coronaryheart disease: a RCSCD-TCM study in China[J]. CardiovascDiabetol, 2022, 21(1):96.
[7] Wang X, Xu W, Song Q, et al. Association between thetriglyceride-glucose index and severity of coronary arterydisease[J]. Cardiovasc Diabetol, 2022, 21(1):168.
[8] Thygesen K, Alpert JS, Jaffe AS, et al. Third universaldefinition of myocardial infarction[J]. Glob Heart, 2012,7(4):275-295.
[9] Ray KK, Colhoun HM, Szarek M, et al. Effects of alirocumabon cardiovascular and metabolic outcomes after acutecoronary syndrome in patients with or without diabetes:a prespecified analysis of the ODYSSEY OUTCOMESrandomised controlled trial[J]. Lancet Diabetes Endocrinol,2019, 7(8):618-628.
[10] Karadeniz F?, Sancaktepe EA, Karadeniz Y. Hightriglyceride-glucose index is associated with poor prognosisin patients with acute coronary syndrome in long-term followup[J]. Angiology, 2023, 74(2):139-148.
[11] Pang S, Miao GR, Zhou YH, et al. Addition of TyG indexto the GRACE score improves prediction of adversecardiovascular outcomes in patients with non-ST-segmentelevation acute coronary syndrome undergoing percutaneouscoronary intervention: a retrospective study[J]. FrontCardiovasc Med, 2022, 9:957626.
[12] Zhang Y, Ding XS, Hua B, et al. High triglyceride-glucoseindex is associated with poor cardiovascular outcomes innondiabetic patients with ACS with LDL-C below 1.8 mmol/L[J].J Atheroscler Thromb, 2022, 29(2):268-281.
[13] Zhu Y, Liu KS, Chen ML, et al. Triglyceride-glucose indexis associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary interventionwith drug-eluting stents[J]. Cardiovasc Diabetol, 2021,20(1):137.
[14] Wu YL, Du LJ, Fan MN, et al. Association betweenoral infections, triglyceride-glucose index, and in-stentrestenosis[J]. Oral Dis, 2022 Nov 2. [Epub ahead of print].
[15] Budoff MJ, Hokanson JE, Nasir K, et al. Progression ofcoronary artery calcium predicts all-cause mortality[J]. JACCCardiovasc Imaging, 2010, 3(12):1229-1236.
[16] Park K, Ahn CW, Lee SB, et al. Elevated TyG index predictsprogression of coronary artery calcification[J]. Diabetes Care,2019, 42(8):1569-1573.
[17] Won KB, Park EJ, Han DH, et al. Triglyceride glucose indexis an independent predictor for the progression of coronaryartery calcification in the absence of heavy coronary arterycalcification at baseline[J]. Cardiovasc Diabetol, 2020,19(1):34.
[18] Song S, Choi SY, Park HE, et al. Incremental prognosticvalue of triglyceride glucose index additional to coronaryartery calcium score in asymptomatic low-risk population[J].Cardiovasc Diabetol, 2022, 21(1):193.
[19] 马丽媛, 王增武, 樊静, 等.《中国心血管健康与疾病报告2021》关于中国高血压流行和防治现状[J]. 中国全科医学,2022, 25(30):3715-3720．
[20] Soleimani M. Insulin resistance and hypertension: newinsights[J]. Kidney Int, 2015, 87(3):497-499.
[21] da Silva AA, do Carmo JM, Li X, et al. Role ofhyperinsulinemia and insulin resistance in hypertension:metabolic syndrome revisited[J]. Can J Cardiol, 2020,36(5):671-682.
[22] Zhu BR, Wang J, Chen K, et al. A high triglyceride glucoseindex is more closely associated with hypertension than lipidor glycemic parameters in elderly individuals: a cross-sectionalsurvey from the Reaction Study[J]. Cardiovasc Diabetol, 2020,19(1):112.
[23] Lee DH, Park JE, Kim SY, et al. Association between thetriglyceride-glucose (TyG) index and increased blood pressurein normotensive subjects: a population-based study[J].Diabetol Metab Syndr, 2022, 14(1):161.
[24] Wu ZY, Zhou D, Liu Y, et al. Association of TyG index andTG/HDL-C ratio with arterial stiffness progression in a nonnormotensivepopulation[J]. Cardiovasc Diabetol, 2021,20(1):134.
[25] Guo W, Zhu WF, Wu J, et al. Triglyceride glucose index isassociated with arterial stiffness and 10-year cardiovasculardisease risk in a Chinese population[J]. Front Cardiovasc Med,2021, 8:585776.
[26] Yan Y, Wang D, Sun Y, et al. Triglyceride-glucose indextrajectory and arterial stiffness: results from HanzhongAdolescent Hypertension Cohort Study[J]. CardiovascDiabetol, 2022, 21(1):33.
[27] Ma LY, Chen WW, Gao RL, et al. China cardiovasculardiseases report 2018: an updated summary[J]. J GeriatrCardiol, 2020, 17(1):1-8.
[28] Gager GM, Gelbenegger G, Jilma B, et al. Cardiovascularoutcome in patients treated with SGLT2 inhibitors for heartfailure: a meta-analysis[J]. Front Cardiovasc Med, 2021,8:691907.
[29] Hattori Y. Insulin resistance and heart failure during treatmentwith sodium glucose cotransporter 2 inhibitors: proposed roleof ketone utilization[J]. Heart Fail Rev, 2020, 25(3):403-408.
[30] Guo WQ, Zhao LY, Mo FR, et al. The prognostic value of thetriglyceride glucose index in patients with chronic heart failureand type 2 diabetes: a retrospective cohort study[J]. DiabetesRes Clin Pract, 2021, 177:108786.
[31] Yang SM, Du YX, Liu ZW, et al. Triglyceride-glucose indexand extracellular volume fraction in patients with heartfailure[J]. Front Cardiovasc Med, 2021, 8:704462.
[32] Han S, Wang CH, Tong F, et al. Triglyceride glucose indexand its combination with the Get with the Guidelines-HeartFailure score in predicting the prognosis in patients with heartfailure[J]. Front Nutr, 2022, 9:950338.
[33] Xu LL, Wu MY, Chen SH, et al. Triglyceride-glucose indexassociates with incident heart failure: a cohort study[J].Diabetes Metab, 2022, 48(6):101365.
[34] de Luca C, Olefsky JM. Inflammation and insulin resistance[J].FEBS Lett, 2008, 582(1):97-105.
[35] Moore SF, Williams CM, Brown E, et al. Loss of theinsulin receptor in murine megakaryocytes/plateletscauses thrombocytosis and alterations in IGF signalling[J].Cardiovasc Res, 2015, 107(1):9-19.
[36] Grant PJ. Diabetes mellitus as a prothrombotic condition[J]. JIntern Med, 2007, 262(2):157-172.
[37] Moore KJ, Tabas I. Macrophages in the pathogenesis ofatherosclerosis[J]. Cell, 2011, 145(3):341-355.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（82060081）
通信作者：赵兴胜， E-mail：zhaoxs1121@163. com
更新日期/Last Update: 2023-11-20